Skip to contentV
Vycor Medical Inc
V
VYCOVycor Medical Inc Q2 2014 · 10-Q
Revenue$298.54K$298.54K+27.1% vs Q2 2013 Net Income-$1.28M-$1.28MN/M vs Q2 2013 EPS Diluted-$0.12-$0.12N/M vs Q2 2013 Gross Profit$262,773+26.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
Operating Cash Flowderived-$699,458N/M Free Cash Flowderived-$731,825N/M Margins · derivedGross margin88.0%−0.1 pt vs Q2 2013
Operating margin-235.7%+23.8 pt vs Q2 2013
Net margin-428.2%−152.5 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 12, 2014 · 43 d after period end